valsartan has been researched along with Neurodegenerative Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allam, EA; Elsharkawy, AM; Hammadi, SH; Hassan, MA; Shams, SS | 1 |
| Janić, M; Lunder, M; Novaković, S; Šabovič, M; Škerl, P | 1 |
1 trial(s) available for valsartan and Neurodegenerative Diseases
| Article | Year |
|---|---|
Expression of Longevity Genes Induced by a Low-Dose Fluvastatin and Valsartan Combination with the Potential to Prevent/Treat "Aging-Related Disorders".
Topics: Adult; Aging; AMP-Activated Protein Kinases; Angiotensin II Type 1 Receptor Blockers; Dose-Response Relationship, Drug; Female; Fluvastatin; Gene Expression; Glucuronidase; Humans; Klotho Proteins; Longevity; Male; Middle Aged; Neurodegenerative Diseases; Placebo Effect; Sirtuin 1; Telomerase; Valsartan | 2019 |
1 other study(ies) available for valsartan and Neurodegenerative Diseases
| Article | Year |
|---|---|
Effect of sacubitril/valsartan on cognitive impairment in colchicine-induced Alzheimer's model in rats.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Cognitive Dysfunction; Colchicine; Drug Combinations; Heart Failure; Male; Neurodegenerative Diseases; Rats; Rats, Wistar; Tetrazoles; Valsartan | 2023 |